<DOC>
	<DOCNO>NCT02139072</DOCNO>
	<brief_summary>The purpose study see CoaguChek XS accurate measure International Normalized Ratio ( INR ) patient Antiphospholipid Antibody Syndrome ( APL ) receive warfarin therapy .</brief_summary>
	<brief_title>CoaguChek XS Antiphospholipid Antibody Syndrome ( APL ) Patients</brief_title>
	<detailed_description>Antiphospholipid Antibody Syndrome ( APL ) autoimmune disease increase one risk blood clot . Therefore , patient receive anticoagulation therapy warfarin . Point care device CoaguChek XS often use monitor International Normalized Ratio ( INR ) patient warfarin . However , antibody present patient APL may lead false INR result use CoaguChek XS . This study compare accuracy CoaguChek XS measure INR patient APL measure INR CoaguChek XS standard lab reference point . Patients warfarin indication APL measure method well serve control group .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Antiphospholipid Syndrome</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies , Antiphospholipid</mesh_term>
	<criteria>1865 year age anticoagulated warfarin least 1 month Diagnosis antiphospholipid antibody syndrome intervention arm type mental disability would hinder ability give inform consent terminal illness condition could interfere study completion , person exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Anticoagulation</keyword>
	<keyword>International normalize ratio</keyword>
	<keyword>Warfarin</keyword>
</DOC>